Estimating the effects of patient-reported outcome (PRO) diarrhea and pain measures on PRO fatigue: Data analysis from a phase II study of abemaciclib monotherapy, a CDK4 and CDK6 inhibitor, in patients with HR+/HER2- breast cancer after chemotherapy for metastatic disease—MONARCH 1.
Mark E. Boye(Eli Lilly (United States)), Gregory L. Price(Eli Lilly (United States)), Claire Ainsworth, Katherine Houghton(RTI Health Solutions), Donald E. Stull(IQVIA (United States))
Cited by 3
Related Papers
Optimal recall periods for patient-reported outcomes: challenges and potential solutions
|Current Medical Research and Opinion|2009|413
Measurement and the Analysis of Burden
|Research on Aging|1985|142
Caregiver Burden and Generic Well-Being: Opposite Sides of the Same Coin?
|The Gerontologist|1994|128
Social Support and Caregiver Distress: A Replication Analysis
|The Journals of Gerontology Series B|2001|100
Becoming a patient with heart failure
|Heart & Lung|1999|92